Trade COCP stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Cocrystal Pharma, Inc. (COCP) is trading at US$1.07, up 0.94% today as of Oct 8, 16:00 EDT. The company has a market capitalisation of US$22.15M. Over the past 52 weeks, COCP has traded between US$0.76 and US$2.03. On Syfe you can trade COCP with $0 commission and add it to your watchlist.
| Previous close | US$1.06 |
|---|---|
| Market cap | US$22.15M |
| 52-week range | US$0.76 – US$2.03 |
| Volume | 29.03K |
| Exchange | US |
Cocrystal Pharma, Inc.
Cocrystal Pharma, Inc. is a clinical-stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication process of influenza viruses, coronaviruses (including SARS-CoV-2), noroviruses and hepatitis C viruses. Cocrystal employs unique structure-based technologies to create first- and best-in-class antiviral drugs. The company was founded in 2008 and is headquartered in Bothell, WA.
Year: 2008
Cocrystal Pharma Appoints James Sapirstein as Chief Executive Officer
Jun 3, 12:02 PM · MT Newswires
Cocrystal Pharma, Inc. (COCP) stock is trading at US$1.07, +0.94% from the previous close of US$1.06.
The market cap for Cocrystal Pharma, Inc. (COCP) stock is approximately US$22.15M.
The 52-week high for Cocrystal Pharma, Inc. (COCP) stock is US$2.03.
The 52-week low for Cocrystal Pharma, Inc. (COCP) stock is US$0.76.
Cocrystal Pharma, Inc. (COCP) does not currently pay a dividend.
Stay on top of COCP
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
